4//SEC Filing
dEsparbes Eric 4
Accession 0000950170-23-043225
CIK 0001580063other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:22 PM ET
Size
6.5 KB
Accession
0000950170-23-043225
Insider Transaction Report
Form 4
dEsparbes Eric
Chief Financial Officer
Transactions
- Award
Common Stock
2023-08-15+219,650→ 278,662 total - Tax Payment
Common Stock
2023-08-15$3.14/sh−40,022$125,669→ 59,012 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.
- [F2]Consists of 219,650 restricted stock units, 25% of which will vest on August 15, 2024, with the remaining shares vesting in equal semi-annual installments through August 15, 2027, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
BIORA THERAPEUTICS, INC.
CIK 0001580063
Entity typeother
Related Parties
1- filerCIK 0001622268
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:22 PM ET
- Size
- 6.5 KB